TriVascular, Inc

Has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR).

Launch date

1998

Employees

11-50 people

Market cap

Enterprise valuation

CAD288m (Public information from Oct 2015)

Santa Rosa California (HQ)

http://trivascular.com

https://twitter.com/trivascular http://www.facebook.com/pages/TriVascular/102676356443234 https://www.linkedin.com/company/trivascular2-inc

Date	Investors	Amount	Round
-	CRG LP	N/A	-
Mar 2008	New Enterprise Associates MPM BioImpact Kearny Venture Partners Delphi Ventures	$65.0m	Series A
Nov 2009	New Enterprise Associates MPM BioImpact Kearny Venture Partners Delphi Ventures	$30.0m	Series B
Aug 2010	New Enterprise Associates MPM BioImpact Kearny Venture Partners Pinnacle Ventures Delphi Ventures	$60.0m	Series C
Jan 2012*	N/A	$50.0m	Debt
Jun 2012	New Enterprise Associates MPM BioImpact Kearny Venture Partners Pinnacle Ventures Kaiser Permanente Ventures Redmile Group Delphi Ventures	$60.0m	Series D
Feb 2013	N/A	$96.0m	Debt
Dec 2013	N/A	$2.0m	Early VC
Apr 2014	N/A	N/A	IPO
Aug 2015	N/A	$10.0m	Post IPO Debt
Oct 2015	Endologix	$211m Valuation: $211m	Acquisition
Total Funding		CAD296m

Tech stackLearn more about the technologies and tools that this company uses.

TriVascular, Inc

TriVascular, Inc

Related Content

Recent News about TriVascular, Inc

Tech stack